Evidence map›Paper›PMID 38065361›Full record

ArticleThe American journal of pathology2024

Vascular Endothelial Growth Factor-C Treatment Enhances Cerebrospinal Fluid Outflow during Toxoplasma gondii Brain Infection but Does Not Improve Cerebral Edema.

Michael A Kovacs, Isaac W Babcock, Ana Royo Marco, Lydia A Sibley, Abigail G Kelly, Tajie H Harris

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of pathology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. The cribriform plate: A dynamic central nervous system-immune hub.The Journal of experimental medicine · 2026
    Review
  4. The neurobiological regulatory mechanism of brain edema.Frontiers in cellular neuroscience · 2026
    Review
  5. Review
  6. From defense to disease: the multifaceted role of lymphatics during infection.Journal of immunology (Baltimore, Md. : 1950) · 2025
    Review
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Michael A KovacsCenter for Brain Immunology and Glia, Department of Neuroscience, University of Virginia, Charlottesville, Virginia.
Isaac W BabcockCenter for Brain Immunology and Glia, Department of Neuroscience, University of Virginia, Charlottesville, Virginia.
Ana Royo MarcoCenter for Brain Immunology and Glia, Department of Neuroscience, University of Virginia, Charlottesville, Virginia.
Lydia A SibleyCenter for Brain Immunology and Glia, Department of Neuroscience, University of Virginia, Charlottesville, Virginia.
Abigail G KellyCenter for Brain Immunology and Glia, Department of Neuroscience, University of Virginia, Charlottesville, Virginia.
Tajie H HarrisCenter for Brain Immunology and Glia, Department of Neuroscience, University of Virginia, Charlottesville, Virginia. Electronic address: tajieharris@virginia.edu.
University of Virginia · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007267 · NIGMS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI GARCIA-BLANCO, MARIANO A. · 1985 to 2024
$13.4M
INTERDISCIPLINARY TRAINING PROGRAM IN IMMUNOLOGYT32AI007496 · NIAID · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Michael G. Brown, Coleen A McNamara · 1995 to 2026
$10.2M
Biotechnology Training ProgramT32GM136615 · NIGMS · UNIVERSITY OF VIRGINIA · PI Silvia Salinas Blemker, Kimberly A. Kelly · 2020 to 2026
$3.4M
Small-Animal 9.4T MRI for Biomedical ResearchS10OD025024 · OD · UNIVERSITY OF VIRGINIA · PI BERR, STUART S. · 2019 to 2019
$2.0M
Alarmin-mediated control of CNS infectionR01NS112516 · NINDS · UNIVERSITY OF VIRGINIA · PI HARRIS, TAJIE H. · 2020 to 2023
$1.9M
Regulatory T cell responses in T. gondii infection of the brainR01NS091067 · NINDS · UNIVERSITY OF VIRGINIA · PI HARRIS, TAJIE H. · 2015 to 2019
$1.8M
Lymphangiogenesis in chronic brain infectionR21NS128551 · NINDS · UNIVERSITY OF VIRGINIA · PI HARRIS, TAJIE H. · 2022 to 2022
$435k
Myeloid cell control of CNS infectionR56NS106028 · NINDS · UNIVERSITY OF VIRGINIA · PI HARRIS, TAJIE H. · 2019 to 2019
$399k
The role of meningeal lymphatic vasculature in regulating immunity and intracranial pressure during central nervous system infectionF30AI154740 · NIAID · UNIVERSITY OF VIRGINIA · PI KOVACS, MICHAEL · 2021 to 2021
$51k
NIAID NIH HHS F30 AI154740NIAID NIH HHS T32 AI007496NIGMS NIH HHS T32 GM007267NIGMS NIH HHS T32 GM136615NINDS NIH HHS R01 NS091067NINDS NIH HHS R01 NS112516NINDS NIH HHS R21 NS128551NINDS NIH HHS R56 NS106028
6 · The paper itself

Abstract

Cerebral edema frequently develops in the setting of brain infection and can contribute to elevated intracranial pressure, a medical emergency. How excess fluid is cleared from the brain is not well understood. Previous studies have shown that interstitial fluid is transported out of the brain along perivascular channels that collect into the cerebrospinal fluid (CSF)-filled subarachnoid space. CSF is then removed from the central nervous system through venous and lymphatic routes. The current study tested the hypothesis that increasing lymphatic drainage of CSF would promote clearance of cerebral edema fluid during infection with the neurotropic parasite Toxoplasma gondii. Fluorescent microscopy and magnetic resonance imaging was used to show that C57BL/6 mice develop vasogenic edema 4 to 5 weeks after infection with T. gondii. Tracer experiments were used to evaluate how brain infection affects meningeal lymphatic function, which demonstrated a decreased rate in CSF outflow in T. gondii-infected mice. Next, mice were treated with a vascular endothelial growth factor (VEGF)-C-expressing viral vector, which induced meningeal lymphangiogenesis and improved CSF outflow in chronically infected mice. No difference in cerebral edema was observed between mice that received VEGF-C and those that rececived sham treatment. Therefore, although VEGF-C treatment can improve lymphatic outflow in mice infected with T. gondii, this effect does not lead to increased clearance of edema fluid from the brains of these mice.

Indexed as

Brain EdemaToxoplasmaToxoplasmosisVascular Endothelial Growth Factor CAnimalsBrainMiceMice, Inbred C57BLVascular Endothelial Growth Factor C

Identifiers

PMID38065361
PMCPMC10835445
OpenAlexW4389410411

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.